New titanium implant aims to get pelvic fracture patients walking again

NCT ID NCT05367505

Ongoing Disease control Sponsor: University of Witten/Herdecke Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests a special titanium implant, called iFuse-3D, along with screws to treat pelvic fractures in people aged 60 and older. The goal is to see if this surgery helps patients get back to their usual walking ability by the time they leave the hospital. Fifty participants will be followed for up to three months to check mobility and recovery.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: iFuse-3D titanium implant and trans-iliac screws
What this could lead to: If successful, this approach could offer a more reliable surgical option for older adults with pelvic fractures, helping them regain mobility faster.
What could go wrong: This is a small, early pilot study with only 50 participants and no comparison group. The implant is already used for other conditions, but its benefit for pelvic fractures is unproven. Surgery always carries risks like infection or implant failure.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for INSUFFICIENCY FRACTURES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Fractures, Stress hip fracture Mobility Limitation

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

INSUFFICIENCY FRACTURES MOBILITY LIMITATION PELVIC FRACTURE

Contacts and locations

Locations

Diakonie Krankenhaus

Bad Kreuznach, 55543, Germany
Helios Universitätsklinikum Wuppertal

Wuppertal, 42283, Germany
University Medical Center of the Johannes Gutenberg University Mainz

Mainz, 55131, Germany

More trials for these conditions

Other studies related to the condition(s) this trial covers.